Vivek S. Tomar

ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes

Zhen Lu, Noreen McBrearty, Jinyun Chen et al. · Cell Metabolism · 2022 · 80 citations · Full text

Life Sciences, Immunology, Oncology +15

Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors

Hongru Zhang, Pengfei Yu, Vivek S. Tomar et al. · Nature Cancer · 2022 · 54 citations · Full text

Medicine, Immunology, Oncology +14

Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer

Zhen Lu, Jinyun Chen, Pengfei Yu et al. · Nature Communications · 2022 · 33 citations · Full text

Medicine, Immunology, Oncology +17

Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment

Hongru Zhang, Vivek S. Tomar, Jinyang Li et al. · Cancer Immunology Research · 2022 · 12 citations · Full text

Medicine, Immunology, Oncology +17